Hollsteen
← ADP

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $4.6B · 10-Q 0000008670-15-000026 filed Nov 5, 2015Equity incl. NCI · Q2 FY2016: $4.2B · 10-Q 0000008670-16-000030 filed Feb 3, 2016Equity incl. NCI · Q3 FY2016: $4.5B · 10-Q 0000008670-16-000034 filed May 5, 2016Equity incl. NCI · Q4 FY2016: $4.5B · 10-K 0000008670-16-000053 filed Aug 5, 2016Equity incl. NCI · Q1 FY2017: $4.2B · 10-Q 0000008670-16-000059 filed Nov 3, 2016Equity incl. NCI · Q2 FY2017: $3.8B · 10-Q 0000008670-17-000003 filed Feb 1, 2017Equity incl. NCI · Q3 FY2017: $4.1B · 10-Q 0000008670-17-000005 filed May 4, 2017Equity incl. NCI · Q4 FY2017: $4.0B · 10-K 0000008670-17-000010 filed Aug 4, 2017Equity incl. NCI · Q1 FY2018: $5.0B · 10-Q 0000008670-19-000005 filed Jan 31, 2019Equity incl. NCI · Q2 FY2018: $5.2B · 10-Q 0000008670-19-000005 filed Jan 31, 2019Equity incl. NCI · Q3 FY2018: $5.3B · 10-Q 0000008670-19-000013 filed May 3, 2019Equity incl. NCI · Q4 FY2018: −$680M · 10-K 0000008670-21-000027 filed Aug 4, 2021Equity incl. NCI · Q1 FY2019: $4.7B · 10-Q 0000008670-18-000017 filed Nov 1, 2018Equity incl. NCI · Q2 FY2019: $4.8B · 10-Q 0000008670-19-000005 filed Jan 31, 2019Equity incl. NCI · Q3 FY2019: $5.2B · 10-Q 0000008670-19-000013 filed May 3, 2019Equity incl. NCI · Q4 FY2019: −$257M · 10-K 0000008670-21-000027 filed Aug 4, 2021Equity incl. NCI · Q1 FY2020: $5.4B · 10-Q 0000008670-19-000027 filed Nov 4, 2019Equity incl. NCI · Q2 FY2020: $5.4B · 10-Q 0000008670-20-000007 filed Jan 31, 2020Equity incl. NCI · Q3 FY2020: $5.5B · 10-Q 0000008670-20-000020 filed May 1, 2020Equity incl. NCI · Q4 FY2020: $5.8B · 10-K 0000008670-20-000032 filed Aug 5, 2020Equity incl. NCI · Q1 FY2021: $5.8B · 10-Q 0000008670-20-000038 filed Oct 30, 2020Equity incl. NCI · Q2 FY2021: $5.9B · 10-Q 0000008670-21-000007 filed Feb 1, 2021Equity incl. NCI · Q3 FY2021: $5.7B · 10-Q 0000008670-21-000014 filed Apr 30, 2021Equity incl. NCI · Q4 FY2021: $5.7B · 10-K 0000008670-21-000027 filed Aug 4, 2021Equity incl. NCI · Q1 FY2022: $5.4B · 10-Q 0000008670-21-000035 filed Oct 29, 2021Equity incl. NCI · Q2 FY2022: $5.0B · 10-Q 0000008670-22-000014 filed Jan 31, 2022Equity incl. NCI · Q3 FY2022: $4.2B · 10-Q 0000008670-22-000023 filed Apr 29, 2022Equity incl. NCI · Q4 FY2022: $3.2B · 10-K 0000008670-22-000038 filed Aug 3, 2022Equity incl. NCI · Q1 FY2023: $2.6B · 10-Q 0000008670-22-000046 filed Nov 2, 2022Equity incl. NCI · Q2 FY2023: $3.0B · 10-Q 0000008670-23-000008 filed Feb 2, 2023Equity incl. NCI · Q3 FY2023: $3.7B · 10-Q 0000008670-23-000017 filed May 1, 2023Equity incl. NCI · Q4 FY2023: $3.5B · 10-K 0000008670-23-000030 filed Aug 3, 2023Equity incl. NCI · Q1 FY2024: $3.5B · 10-Q 0000008670-23-000040 filed Nov 2, 2023Equity incl. NCI · Q2 FY2024: $4.3B · 10-Q 0000008670-24-000007 filed Feb 1, 2024Equity incl. NCI · Q3 FY2024: $4.6B · 10-Q 0000008670-24-000014 filed May 2, 2024Equity incl. NCI · Q4 FY2024: $4.5B · 10-K 0000008670-24-000024 filed Aug 7, 2024Equity incl. NCI · Q1 FY2025: $5.3B · 10-Q 0000008670-24-000030 filed Nov 1, 2024Equity incl. NCI · Q2 FY2025: $5.1B · 10-Q 0000008670-25-000007 filed Jan 30, 2025Equity incl. NCI · Q3 FY2025: $5.9B · 10-Q 0000008670-25-000015 filed May 1, 2025Equity incl. NCI · Q4 FY2025: $6.2B · 10-K 0000008670-25-000037 filed Aug 6, 2025Equity incl. NCI · Q1 FY2026: $6.4B · 10-Q 0000008670-25-000047 filed Oct 31, 2025Equity incl. NCI · Q2 FY2026: $6.4B · 10-Q 0000008670-26-000011 filed Jan 29, 2026Equity incl. NCI · Q3 FY2026: $6.3B · 10-Q 0000008670-26-000022 filed Apr 30, 2026Equity incl. NCI · Q4 FY2026: $6.0B · 10-K 0000008670-26-000030 filed Aug 5, 20265,3646,0314,630Q1 FY2016Q4 FY2026Q2 FY2020
$MEquity incl. NCI · Q2 FY2019: $4.8B · 10-Q 0000008670-19-000005 filed Jan 31, 2019Equity incl. NCI · Q3 FY2019: $5.2B · 10-Q 0000008670-19-000013 filed May 3, 2019Equity incl. NCI · Q4 FY2019: −$257M · 10-K 0000008670-21-000027 filed Aug 4, 2021Equity incl. NCI · Q1 FY2020: $5.4B · 10-Q 0000008670-19-000027 filed Nov 4, 2019Equity incl. NCI · Q2 FY2020: $5.4B · 10-Q 0000008670-20-000007 filed Jan 31, 2020Equity incl. NCI · Q3 FY2020: $5.5B · 10-Q 0000008670-20-000020 filed May 1, 2020Equity incl. NCI · Q4 FY2020: $5.8B · 10-K 0000008670-20-000032 filed Aug 5, 2020Equity incl. NCI · Q1 FY2021: $5.8B · 10-Q 0000008670-20-000038 filed Oct 30, 20205,3645,8094,764Q2 FY2019Q1 FY2021Q2 FY2020
Q2 FY2020
5,364$M
All values (44)
PeriodValue ($M)Status
Q4 FY20266,031reported
Q3 FY20266,350reported
Q2 FY20266,393reported
Q1 FY20266,374reported
Q4 FY20256,188reported
Q3 FY20255,855reported
Q2 FY20255,078reported
Q1 FY20255,349reported
Q4 FY20244,548reported
Q3 FY20244,627reported
Q2 FY20244,320reported
Q1 FY20243,473reported
Q4 FY20233,509reported
Q3 FY20233,694reported
Q2 FY20232,987reported
Q1 FY20232,576reported
Q4 FY20223,225reported
Q3 FY20224,193reported
Q2 FY20225,050reported
Q1 FY20225,351reported
Q4 FY20215,670reported
Q3 FY20215,674reported
Q2 FY20215,900reported
Q1 FY20215,809reported
Q4 FY20205,752reported
Q3 FY20205,491reported
Q2 FY20205,364reported
Q1 FY20205,361reported
Q4 FY2019−257reported
Q3 FY20195,246reported
Q2 FY20194,764reported
Q1 FY20194,679reported
Q4 FY2018−680reported
Q3 FY20185,282reported
Q2 FY20185,160reported
Q1 FY20184,982reported
Q4 FY20173,977reported
Q3 FY20174,103reported
Q2 FY20173,815reported
Q1 FY20174,250reported
Q4 FY20164,482reported
Q3 FY20164,503reported
Q2 FY20164,206reported
Q1 FY20164,630reported

CSV with all sources · Technical ID: equity_total

More metrics for ADP

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$5.4B
Period
Q2 FY2020, ended Dec 31, 2019 · as of Dec 31, 2019 (balance as of date, not a sum)
Source
10-Q, filed Jan 31, 2020 · 0000008670-20-000007
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.4BJan 31, 202010-Q 0000008670-20-000007reported · confidence 1. · current